Pedmark
(PED-mark)
A drug used to reduce the risk of hearing loss in children aged 1 month and older who are receiving cisplatin (a type of anticancer drug) for solid tumors that have not spread to other parts of the body. It is also being studied in the prevention and treatment of other conditions. Pedmark is a type of chemoprotective agent. Also called sodium thiosulfate anhydrous.